# US 12,602,732 B2 · System and methods for securing a drug therapy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 12,602,732 B2
- Document ID: US12602732B2
- Status: Granted
- Kind: B2
- Application number: 18/342,273
- Filed: 2023-06-27
- Published: 2023-10-26
- Granted: 2026-04-14
- Earliest claimed: 2019-06-26
- Assignees: Pharmaccx, Inc.
- Applicants: PharmaCCX, Inc.
- Inventors: Armen Solakhyan; Peter Rice; Richard Bergström; Patrick Schneider; Cole Boskey
- Web page: https://patentgrep.com/patent/US12602732B2

## CPC

- G06Q 50/188: {Electronic negotiation}
- G06F 16/258: {Data format conversion from or to a database}
- G06Q 30/0206: {Price or cost determination based on market factors}
- G06Q 30/0234: Rebates after completed purchase
- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H 40/20: for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16H 50/30: for calculating health indices; for individual health risk assessment
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- G16H 70/20: relating to practices or guidelines
- G16H 70/40: relating to drugs, e.g. their side effects or intended usage
- A61B 5/1072: {measuring distances on the body, e.g. measuring length, height or thickness (A61B5/1076 takes precedence)}
- G06Q: INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06F: ELECTRIC DIGITAL DATA PROCESSING (computer systems based on specific computational models G06N)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A system for negotiating a purchase of a pharmaceutical treatment between a provider of the pharmaceutical treatment and a plurality of purchasers of the pharmaceutical treatment. The method receives one or more assumptions associated with a patient. An input field in a graphical user interface of a first computing device is displayed where the first computing device received an offer to purchase the pharmaceutical treatment from the purchaser. The offer to purchase is received from the first computing device via a network. The offer to purchase is modified. The modified offer to purchase is displayed on a second computing device that is associated with a provider of the pharmaceutical treatment via a graphical user interface on the second computing device. An input field in the graphical user interface of the second computing device that is configured to receive, from the provider, an offer to provide the pharmaceutical treatment is displayed.

## Claims

### Claim 1

A method for negotiating a purchase of a pharmaceutical treatment between a provider of the pharmaceutical treatment and a plurality of purchasers of the pharmaceutical treatment, comprising:
receiving one or more assumptions associated with a patient, the one or more assumptions comprising:
an indication of an agreement upon the one or more assumptions between the provider and the plurality of purchasers,
an average patient body surface area,
an average patient weight, and
a date associated with the indication of the agreement;
causing display, using a first display on a first computing device that is associated with a purchaser of the plurality of purchasers, of an input field in a graphical user interface of the first computing device that is configured to receive, from the purchaser, an offer to purchase the pharmaceutical treatment, the offer to purchase comprising:
a number of patients eligible for the pharmaceutical treatment,
an expected rebate, and
an expected price-per-patient;
causing display, using the first display on the first computing device, of a user-toggleable input field in the graphical user interface that is configured to receive, from the purchaser, a choice to hide the expected price-per-patient;
receiving, from the first computing device via a network, the offer to purchase;
modifying the offer to purchase by (a) excluding one or more parameters of the offer to purchase based on an administrator-defined permission, and (b) converting the expected price-per-patient to an expected price-per pack of the pharmaceutical treatment;
causing display, using a second display on a second computing device that is associated with the provider of the pharmaceutical treatment, of the modified offer to purchase via a graphical user interface of the second computing device;
causing obfuscation, using the second display, of the expected price-per-pack by replacing the expected price-per-pack with an obfuscation token based on the purchaser selecting the choice to hide the expected price-per-patient via the user-toggleable input field on the first display;
further causing display, using the second display on the second computing device, of an input field in the graphical user interface of the second computing device that is configured to receive, from the provider, an offer to provide the pharmaceutical treatment, the offer to provide comprising an offered price-per-pack;
receiving, from the second computing device via the network, the offer to provide;
modifying the offer to provide by converting the offered price-per-pack to an offered price-per-patient;
determining a probability of success of a round of negotiation between the plurality of purchasers and the provider, the probability of success based upon a percentage associated with a difference between the offer to purchase price and the offered price-per-patient
causing display, using the first display on the first computing device, of the modified offer to provide; and
further causing display, using a third display on a third computing device that is associated with a further purchaser of the plurality of purchasers, of a further modified offer to provide and a recommendation to purchase the pharmaceutical treatment that is based on the probability of success, the recommendation including a recommended adjustment to one or more of: an assumption of the one or more assumptions, the modified offer to purchase, the offered price-per-patient, and the offer to purchase price,
wherein the display of the modified offer to provide using the first display on the first computing device and the further display of the further modified offer to provide on the third computing device using the third display are different at least based on the administrator-defined permission.

### Claim 2 (depends on 1)

The method of claim 1, wherein the number of patients eligible for the pharmaceutical treatment is one.

### Claim 3 (depends on 1)

The method of claim 1, wherein the offer to purchase comprises a maximum number of rounds of negotiations.

### Claim 4 (depends on 1)

The method of claim 1, wherein the round of negotiation is at least a second round of negotiation.

### Claim 5 (depends on 1)

The method of claim 1, wherein the pharmaceutical treatment comprises multiple therapies that can be used to treat a same disease or indication.

### Claim 6 (depends on 1)

The method of claim 1, further comprising providing a platform for a binding negotiation and a platform for a simulated negotiation.

### Claim 7 (depends on 1)

The method of claim 1, wherein the probability of success of a negotiation between the plurality of purchasers of the pharmaceutical treatment and the provider of the pharmaceutical treatment is further based upon one or more of a therapy continuation factor and therapy discontinuation factor.

### Claim 8 (depends on 1)

The method of claim 1, wherein the pharmaceutical treatment includes one or more products and the provider of the pharmaceutical treatment includes a plurality of providers, the plurality of providers each associated with at least a portion of the one or more products.

### Claim 9 (depends on 1)

The method of claim 1, wherein the modified offer to purchase adheres to an anti-trust regulation.

### Claim 10

A non-transitory computer-readable storage medium for storing instructions that, when executed by a processor, cause the processor to:
receive one or more assumptions associated with a patient, the one or more assumptions comprising:
an indication of an agreement upon the one or more assumptions between the provider and the plurality of purchasers,
an average patient body surface area,
an average patient weight, and
a date associated with the indication of the agreement;
cause display, using a first display on a first computing device that is associated with a purchaser of the plurality of purchasers, of an input field in a graphical user interface of the first computing device that is configured to receive, from the purchaser, an offer to purchase the pharmaceutical treatment, the offer to purchase comprising:
a number of patients eligible for the pharmaceutical treatment,
an expected rebate, and
an expected price-per-patient;
receive, from the first computing device via a network, the offer to purchase;
cause display, using the first display on the first computing device, of a user-toggleable input field in the graphical user interface that is configured to receive, from the purchaser, a choice to hide the expected price-per-patient;
modify the offer to purchase by (a) excluding one or more parameters of the offer to purchase based on an administrator-defined permission, and (b) converting the expected price-per-patient to an expected price-per pack of the pharmaceutical treatment;
cause display, using a second display on a second computing device that is associated with a provider of the pharmaceutical treatment, of the modified offer to purchase via a graphical use interface of the second computing device;
cause obfuscation, using the second display, of the expected price-per-pack by replacing the expected price-per-pack with an obfuscation token based on the purchaser selecting the choice to hide the expected price-per-patient via the user-toggleable input field on the first display;
further cause display, using a second display on the second computing device, of an input field in the graphical user interface of the second computing device that is configured to receive, from the provider, an offer to provide the pharmaceutical treatment, the offer to provide comprising an offered price-per-pack;
receive, from the second computing device via the network, the offer to provide;
modify the offer to provide by converting the offered price-per-pack to an offered price-per-patient;
determine a probability of success of a round of a negotiation between the plurality of purchasers and the provider, the probability of success based upon a percentage associated with a difference between the offer to purchase price and the offered price-per-patient;
cause display, using a third display on a third computing device that is associated with a further purchaser of the plurality of purchasers, of a further modified offer to provide and a recommendation to purchase the pharmaceutical treatment that is based on the probability of success, the recommendation including a recommended adjustment to one or more of: an assumption of the one or more assumptions, the modified offer to purchase, the offered price-per-patient, and the offer to purchase price,
wherein the display of the modified offer to provide using the first display on the first computing device and the further display of the further modified offer to provide using the third display on the third computing device are different at least based on the administrator-defined permission.

### Claim 11 (depends on 10)

The non-transitory computer-readable storage medium of claim 10, wherein the number of patients eligible for the pharmaceutical treatment is one.

### Claim 12 (depends on 10)

The non-transitory computer-readable storage medium of claim 10, wherein the round of negotiation is at least a second round of negotiation.

### Claim 13 (depends on 10)

The non-transitory computer-readable storage medium of claim 10, wherein the offer to purchase comprises a maximum number of rounds of negotiations.

### Claim 14 (depends on 10)

The non-transitory computer-readable storage medium of claim 10, wherein the pharmaceutical treatment comprises multiple therapies that can be used to treat a same disease or indication.

### Claim 15 (depends on 10)

The non-transitory computer-readable storage medium of claim 10, wherein excluding one or more parameters of the offer to purchase based on an administrator-defined permission comprises adhering to a country specific rule.

### Claim 16 (depends on 10)

The non-transitory computer-readable storage medium of claim 10, wherein the pharmaceutical treatment includes one or more products, the provider of the pharmaceutical treatment includes a plurality of providers, each of the plurality of providers associated with at least a portion of the one or more products.

### Claim 17 (depends on 10)

The non-transitory computer-readable storage medium of claim 10, wherein the modified offer to purchase adheres to an anti-trust regulation.

### Claim 18 (depends on 1)

The method of claim 1, wherein the administrator-defined permission is based on a geographic limitation.

### Claim 19 (depends on 1)

The method of claim 1, wherein the administrator-defined permission is based on an identity of an insurance plan.

### Claim 20 (depends on 1)

The method of claim 1, wherein the administrator-defined permission is based on an identity of an employer.